7 to 7,000 Employees in 9 Months

Categories: VC, Startup

Summary

Curative scaled from 7 to 7,000 employees in 9 months during COVID by pivoting a homemade test into a mass testing operation (26,000 tests/day peak), then failed to sustain post-pandemic—demonstrating how crisis-driven hypergrowth can mask unsustainable unit economics and require radical cost restructuring (80% SaaS cuts).

Key Takeaways

  1. Hypergrowth can mask broken economics: Curative hit $5B revenue during COVID but accumulated massive losses on vaccination services, revealing that rapid scaling without unit economics discipline creates debt, not value.
  2. Crisis creates supply-demand mismatch opportunities: The CSO built a COVID test in spare time when tests were unavailable, capturing immediate market demand—but this advantage evaporates post-crisis, making sustainability critical from day one.
  3. Scaling to 7K employees in 9 months requires ruthless cost discipline post-crisis: After revenue collapsed, cutting 80% of SaaS spend became necessary—suggesting founders should model post-crisis scenarios and avoid fixed cost structures that don't scale with revenue cycles.
  4. Diversification into low-margin services (2.5M vaccinations) can destroy profitability: Even at scale, offering services outside core competency became a liability—founders should focus narrowly on defensible, profitable unit economics rather than chasing volume.
  5. Crisis-driven pivots need long-term business model validation: Curative pivoted to health insurance ($1.3B valuation) post-COVID, showing successful founders can survive and rebuild—but only by fundamentally rethinking the business, not extending legacy crisis plays.

Related topics

Transcript Excerpt

Lockdowns had just started. Everybody was starting to freak out. There was basically nowhere to get a test. So, our chief scientific officer had in his spare time developed a COVID test. I think our peak day was 26,000 people tested in a single day. I'm so excited for a freaking wild story today. Fred Turner, co-founder and CEO of Curative. This is an English founder in the valley who scaled a COVID testing business to $5 billion in revenue. Then he had to scale it all back. It did not last postcoid for obvious reasons. Today, he turned it into a health insurance provider that's worth $1.3 billion. And in the show, he says some pretty wild stuff. And the company went from about 7 to 7,000 employees in those first 9 months. We did 2 and a half million vaccinations. That was another service …

More from 20VC